Processa Pharmaceuticals, Inc. Stock
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
09:40:28 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 1.410 USD | +4.44% |
|
-26.40% | -58.85% |
| Market Cap | 4.52M 4.04M 3.77M 3.42M 6.44M 438M 6.51M 45.26M 17.7M 223M 16.99M 16.62M 716M | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | -1.01M -904K -843K -766K -1.44M -98.02M -1.46M -10.12M -3.96M -49.81M -3.8M -3.72M -160M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PCSA | Delayed | |
CBOE
| PCSA | Real-time |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | -12.22% | ||
| 1 week | -26.40% | ||
| Current month | -27.74% | ||
| 1 month | -40.45% | ||
| 3 months | -39.85% | ||
| 6 months | -60.10% | ||
| Current year | -58.85% |
| 1 week | 1.04 | 1.63 | |
| 1 month | 1.04 | 2.12 | |
| Current year | 1.04 | 3.8 | |
| 1 year | 1.04 | 11.08 | |
| 3 years | 1.04 | 450 | |
| 5 years | 1.04 | 4,125 | |
| 10 years | 1.04 | 125,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 2023-08-07 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 2011-03-28 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 2017-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 2011-03-28 |
Justin Yorke
CHM | Chairman | 60 | 2022-08-15 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 2020-02-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/8/26 | Exercice | Chief Executive Officer | 3,200 | 0.1156% | ||
| 7/26/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 7/26/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.44% | -26.40% | -87.93% | -98.72% | 4.52M | ||
| -3.19% | -3.19% | +44.60% | +87.98% | 72.13B | ||
| +3.68% | -10.25% | +5.36% | +56.70% | 49.41B | ||
| +2.04% | +1.24% | +5.22% | +33.47% | 47.24B | ||
| -1.63% | -8.25% | +298.16% | +644.35% | 40.32B | ||
| +0.94% | +0.26% | +27.52% | +29.73% | 42.61B | ||
| +0.64% | -2.40% | +4.07% | +102.26% | 39.81B | ||
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | ||
| +2.79% | -4.44% | -11.37% | -15.29% | 23.13B | ||
| +3.42% | +7.93% | +17.97% | -0.04% | 21.09B | ||
| Average | -0.58% | -4.96% | +31.11% | +89.08% | 36.63B | |
| Weighted average by Cap. | +0.33% | -3.85% | +47.59% | +118.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -11.85M -10.58M -9.87M -8.97M -16.87M -1.15B -17.04M -119M -46.36M -583M -44.49M -43.53M -1.88B | -13.56M -12.11M -11.3M -10.26M -19.32M -1.31B -19.5M -136M -53.06M -668M -50.93M -49.82M -2.15B |
| Net Debt | -1.12M -998K -931K -846K -1.59M -108M -1.61M -11.18M -4.37M -55.01M -4.2M -4.11M -177M | -5.54M -4.94M -4.61M -4.19M -7.88M -536M -7.96M -55.38M -21.66M -272M -20.79M -20.34M -876M |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-09 | US$1.210 | -10.37% | 127,839 |
| 26-10-08 | US$1.350 | -4.93% | 12,803 |
| 26-10-07 | US$1.420 | -6.58% | 12,904 |
| 26-10-06 | US$1.520 | +2.01% | 18,585 |
| 26-10-05 | US$1.490 | -7.45% | 25,737 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions

















